Scientific Publications Database
Article Title: Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic dataAuthors: Bjarnason, G. A.; Knox, J.; Kollmannsberger, C. K.; Soulieres, D.; Ernst, D. S.; Zalewski, P.; Canil, C. M.; Winquist, E.; Hotte, S. J.; North, S. A.; Heng, D. Y. C.; Macfarlane, R. J.; Venner, P. M.; Kapoor, A.; Hansen, A. R.; Czaykowski, P.; Boyd, B.; Wang, L.; Basappa, N. S.
Journal: ANNALS OF ONCOLOGY Volume 28
Date of Publication:2017
Abstract:
.